Biokraft International AB reaffirmed earnings guidance for 2023. As previously communicated, 2023 will show weak underlying profitability given that company have a large share of fixed delivery contracts with fixed low prices that do not allow compensation for sharply increased costs.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
20.2 SEK | +1.00% | 0.00% | -0.74% |
1st Jan change | Capi. | |
---|---|---|
-0.74% | 80.29M | |
-34.93% | 362M | |
+43.50% | 166M | |
-11.14% | 100M |
- Stock Market
- Equities
- BIOGAS Stock
- News Biokraft International AB
- Biokraft International AB Reaffirms Earnings Guidance for 2023